Ibudilast could also potentially be inhibiting the DNA binding activity of NF-κB, as has been reported with the type 3 PDE inhibitor, cilostazol [52].
Similar enhancements in various properties have also been reported with other types of nanofillers e.g. multiwalled carbon nanotubes and layered double hydroxides [11, 12].
Increases in the relative abundance of Proteobacteria have been reported with various types of intestinal tract disease in diverse species such as humans, horses and dogs [ 13, 14, 18, 20].
Background: Although dry mouth (xerostomia) has been reported with botulinum toxin type B used as treatment for cervical dystonia, the impact of this adverse effect (AE) on patients' activities of daily living (ADLs) has not been assessed.
Similar experiences have also been reported with Shigella dysenteriae type 1, another enteric pathogen that causes life-threatening disease and has epidemic potential.
Scleritis and peripheral ulcerative keratitis have been reported with hepatitis C-related type III cryoglobulinemia [3].
Patients have been reported with impairments for all types of knowledge about a particular category such as, for instance, living things.
Worldwide, less than 50 patients are reported with platelet type von Willebrand disease (PT-VWD).
Significant noise reductions and improved diagnostic confidence are reported with both types [ 15– 215.
